drugset / Trial / NCT02201030
Immunogenicity and Safety Study of NBP606 in Healthy Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will assess the immunogenicity and safety of primary vaccination with NBP606 compared to the existing commercial vaccine, when given concomitantly with routine pediatric vaccinations.
Timeline
- Start
- 2014-09-06
- Primary completion
- 2016-10-21
- Completion
- 2016-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NBP606 | Unknown | — | Intramuscular |
| Comparator | Prevnar 13 | Vaccine | — | Intramuscular |